Subsequently, a potential correlation between AML patient survival and activation of DNMT3A and Tet2 was reported, providing a novel strategy for improving AML patient survival by altering the normal methylation patterns of specific genes (Ponciano-Gomez et al., 2017). Here, TET2 is linked to acute myeloid leukemia.